OneDigital Investment Advisors’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-108,900
Closed -$3K 806
2022
Q1
$3K Hold
108,900
﹤0.01% 752
2021
Q4
$359K Hold
108,900
0.01% 544
2021
Q3
$3K Hold
108,900
﹤0.01% 755
2021
Q2
$3K Hold
108,900
﹤0.01% 738
2021
Q1
$3K Hold
108,900
﹤0.01% 685
2020
Q4
$3K Hold
108,900
﹤0.01% 686
2020
Q3
$3K Hold
108,900
﹤0.01% 648
2020
Q2
$3K Hold
108,900
﹤0.01% 638
2020
Q1
$3K Buy
108,900
+98,010
+900% +$486K ﹤0.01% 556
2019
Q4
$3K Buy
+10,890
New +$80.2K ﹤0.01% 594

Other funds holding AVEO

OneDigital Investment Advisors's AVEO Position: Q4 2020 in Review

OneDigital Investment Advisors sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2020, closing a stake of 2,560 shares — an estimated $14.7K sold.

OneDigital Investment Advisors first reported a position in AVEO in Q3 2020 and held it in 1 quarter. The position peaked at $15K in Q3 2020. 65 funds tracked by Wall St. Rank hold AVEO as of Q4 2020.

  • OneDigital Investment Advisors reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • OneDigital Investment Advisors sold 2,560 AVEO Pharmaceuticals, Inc. shares in Q4 2020, an estimated $14.7K.
  • OneDigital Investment Advisors first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • OneDigital Investment Advisors's AVEO Pharmaceuticals, Inc. position peaked at $15K in Q3 2020.
  • 65 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2020.

Based on OneDigital Investment Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.